妊娠中の血液学的癌
Benjamin Brenner1, Irit Avivi, Michael Lishner
1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel. b_brenner@rambam.health.gov.il
Lancet (London, England)
|February 14, 2012
まとめ
妊娠中の血液がんの診断と治療は,重複する症状と限られたデータのために困難です. マネジメントは母親の健康を優先し,妊娠後の治療はしばしば実行可能である.
科学分野:
- 血液学 ヘマトロジ
- 腫瘍学 腫瘍学
- 産科・婦人科 産科・婦人科
背景:
- 妊娠中の血液学的癌は稀ですが,母親と胎児にとって高いリスクがあります.
- ホジキンリンパ腫,ノンホジキンリンパ腫,急性白血病は最も一般的なタイプです.
- 妊娠と癌の症状が重複し,画像検査の限界があるため,診断は複雑です.
研究 の 目的:
- 妊娠中の血液学的癌の管理に関する最新のガイドラインを提供すること.
- 化学療法と生物学的薬剤による治療に重点を置く.
- この集団における診断と治療の複雑さに対処するために.
主な方法:
- 既存の文献と遡及データのレビュー.
- 化学療法および生物学的薬剤の安全性および有効性に焦点を当てます.
- 現在の知識と臨床的検討に基づいてガイドラインの開発.
主要な成果:
- 母親の健康を維持することが,治療の第一の目標です.
- 適切な治療のために,早期に妊娠中絶を推奨することがあります.
- 治療は,後期の妊娠段階ではしばしば実行可能である.
- 高血栓性のリスクが増加すると,血栓予防療法が必要になります.
結論:
- 妊娠中の血液学的癌の管理には,多学科的なアプローチが必要です.
- 将来の研究を含むさらなる共同研究が不可欠です.
- 病気のメカニズムと疫学データの理解は,改善された結果のために不可欠です.
関連する概念動画
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
